Cargando…
Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes
β(2)‐Adrenoceptor (β(2)‐AR) signaling decreases the transcriptional activity of forkhead box O (FoxO), but the underlying mechanisms remain incompletely understood. Here, we investigated how β(2)‐AR signaling regulates the protein abundance of FoxO and its transcriptional activity in skeletal muscle...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886325/ https://www.ncbi.nlm.nih.gov/pubmed/35038382 http://dx.doi.org/10.1002/2211-5463.13368 |
_version_ | 1784660644788699136 |
---|---|
author | Shimamoto, Saki Nakashima, Kazuki Nishikoba, Nao Kohrogi, Rukana Ohtsuka, Akira Fujimura, Shinobu Ijiri, Daichi |
author_facet | Shimamoto, Saki Nakashima, Kazuki Nishikoba, Nao Kohrogi, Rukana Ohtsuka, Akira Fujimura, Shinobu Ijiri, Daichi |
author_sort | Shimamoto, Saki |
collection | PubMed |
description | β(2)‐Adrenoceptor (β(2)‐AR) signaling decreases the transcriptional activity of forkhead box O (FoxO), but the underlying mechanisms remain incompletely understood. Here, we investigated how β(2)‐AR signaling regulates the protein abundance of FoxO and its transcriptional activity in skeletal muscle. We observed that stimulation of β(2)‐AR with its selective agonist, clenbuterol, rapidly decreased FoxO1 mRNA expression, and this was accompanied by a decrease in either FoxO1 protein level or FoxO transcriptional activity. We subsequently observed that miR‐374b‐5p and miR‐7a‐1‐3p were rapidly upregulated in response to β(2)‐AR stimulation. Transfection with mimics of either miRNA successfully decreased FoxO1 mRNA. Moreover, because β(2)‐AR stimulation increased cAMP concentration, pretreatment with an adenylyl cyclase inhibitor canceled out these effects of β(2)‐AR stimulation. These results suggest that β(2)‐AR stimulation results in rapid upregulation of miR‐374b‐5p and miR‐7a‐1‐3p in myotubes, which in turn results in a decrease in FoxO1 mRNA expression via the β(2)‐AR–cAMP signaling pathway. |
format | Online Article Text |
id | pubmed-8886325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88863252022-03-04 Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes Shimamoto, Saki Nakashima, Kazuki Nishikoba, Nao Kohrogi, Rukana Ohtsuka, Akira Fujimura, Shinobu Ijiri, Daichi FEBS Open Bio Research Articles β(2)‐Adrenoceptor (β(2)‐AR) signaling decreases the transcriptional activity of forkhead box O (FoxO), but the underlying mechanisms remain incompletely understood. Here, we investigated how β(2)‐AR signaling regulates the protein abundance of FoxO and its transcriptional activity in skeletal muscle. We observed that stimulation of β(2)‐AR with its selective agonist, clenbuterol, rapidly decreased FoxO1 mRNA expression, and this was accompanied by a decrease in either FoxO1 protein level or FoxO transcriptional activity. We subsequently observed that miR‐374b‐5p and miR‐7a‐1‐3p were rapidly upregulated in response to β(2)‐AR stimulation. Transfection with mimics of either miRNA successfully decreased FoxO1 mRNA. Moreover, because β(2)‐AR stimulation increased cAMP concentration, pretreatment with an adenylyl cyclase inhibitor canceled out these effects of β(2)‐AR stimulation. These results suggest that β(2)‐AR stimulation results in rapid upregulation of miR‐374b‐5p and miR‐7a‐1‐3p in myotubes, which in turn results in a decrease in FoxO1 mRNA expression via the β(2)‐AR–cAMP signaling pathway. John Wiley and Sons Inc. 2022-02-07 /pmc/articles/PMC8886325/ /pubmed/35038382 http://dx.doi.org/10.1002/2211-5463.13368 Text en © 2022 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Shimamoto, Saki Nakashima, Kazuki Nishikoba, Nao Kohrogi, Rukana Ohtsuka, Akira Fujimura, Shinobu Ijiri, Daichi Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes |
title | Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes |
title_full | Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes |
title_fullStr | Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes |
title_full_unstemmed | Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes |
title_short | Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes |
title_sort | suppression of foxo1 mrna by β(2)‐adrenoceptor–camp signaling through mir‐374b‐5p and mir‐7a‐1‐3p in c2c12 myotubes |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886325/ https://www.ncbi.nlm.nih.gov/pubmed/35038382 http://dx.doi.org/10.1002/2211-5463.13368 |
work_keys_str_mv | AT shimamotosaki suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes AT nakashimakazuki suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes AT nishikobanao suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes AT kohrogirukana suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes AT ohtsukaakira suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes AT fujimurashinobu suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes AT ijiridaichi suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes |